Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT03800316
The study team aims to test connectivity metrics and follow patient outcomes using a new, innovative synchronous video technology in the prehospital setting in three distinct areas:
1. - 911 Calls 2. - Pediatric Critical Care Transport
Currently, paramedics and pediatric transport teams seek advice from physicians using a telephone. This project replaces the phone with video consultation where the physicians can directly interact with patients, paramedics and transport teams when care advice is needed.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Video consultation with emergency medicine physicians for patients that are critically ill prior to arrival in the ED
Time frame: 1 year
Total number of video consultations completed
Time frame: 1 year
Total number of subject deaths
Time frame: 1 year
Total number of hours subjects were admitted to the hospital
Time frame: 1 year
Total number of hours subjects were admitted to the emergency room
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06497725
Disease Attributes, Emergencies
Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT04452695
COVID-19, Communicable Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04497922
Behavior, COVID-19
Boston, Massachusetts, United States
View Trial DetailsNCT04916028
Chemically-Induced Disorders, Disease Attributes
Amiens, France
View Trial Details